Drugs / L-Citruline
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05029778 | Oct 2021 | fetal growth restriction | Hospital Civil de Guadalajara | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-Citruline | “receive L-arginine 3g + l-Citruline 2 g PO, for 24 h, until birth.” NCT05029778 ↗ |
| Known as | l-citrulline | “The aim of the study was to determine whether l-citrulline supplementation would enhance fetal growth in a model of IUGR induced by maternal dietary protein restriction.” PMID 26865647 ↗ Feb 2016 |
| Route | Oral | “receive L-arginine 3g + l-Citruline 2 g PO, for 24 h, until birth.” NCT05029778 ↗ |